Patient Enrollment Marketing for Phase II Heart Failure Study

February 9, 2018

Challenge

The sponsor knew that their protocol design and I/E criteria would result in less than 0.25% of patient candidate charts being eligible for enrollment. As such, they needed a system, process and expertise to identify every potential chart and patient for their extremely challenging Class III heart failure study.

Solution

ThreeWire launched our Chart Review™ service at each of the three participating sites, using highly skilled cardiac electrophysiology nurses with extensive experience in similar studies. It was essential that these nurses could expertly evaluate chart data in light of the continual dynamic changes in heart failure metrics for Class III patients.

Results

Within three weeks, we reviewed 1,311 charts, identified 80 potential study candidates, and contributed 2 enrollments

Previous Flipbook
Patient Enrollment Marketing for Phase II OAB Drug- Europe
Patient Enrollment Marketing for Phase II OAB Drug- Europe

Jump start enrollment at a small number of key sites in order to generate momentum for quickly enrolling th...

Next Flipbook
Patient Enrollment Marketing for Uterine Fibroids Medical Device Study
Patient Enrollment Marketing for Uterine Fibroids Medical Device Study

Launch a direct-to-patient marketing campaign for a medical device therapy used to treat uterine fibroids a...